Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex
Conditions: Angiofibroma of Face; Tuberous Sclerosis Interventions: Drug: Sirolimus 0.2%; Drug: Sirolimus 0.4%; Drug: Placebo ointment Sponsor: Aucta Pharmaceuticals, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Tuberous Sclerosis